NEoAdjuvant radiohormonal therapy versus standard of care for oligometastatic prostate cancer (NEAR-TOP): study protocol of a multicenter, open-label, randomised controlled trial by Zhiguo Fan, Duocai Li, Shi Yan, Xianzhi Zhao, Lei Yin, Weidong Xu, Ye Wang, Huojun Zhang, Yifan Chang, Shancheng Ren

Get full text